Douglas P Ostrander, MS, PT | |
10450 W Mcdowell Rd Ste 102, Avondale, AZ 85392-4901 | |
(602) 648-5444 | |
(602) 772-3801 |
Full Name | Douglas P Ostrander |
---|---|
Gender | Male |
Speciality | Physical Therapy |
Experience | 28 Years |
Location | 10450 W Mcdowell Rd Ste 102, Avondale, Arizona |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1023012887 | NPI | - | NPPES |
02250562 | Medicaid | NY |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225100000X | Physical Therapist | 016280 (New York) | Secondary |
225100000X | Physical Therapist | 10803 (Arizona) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Orthopedic Specialists Of North America Pllc | 7719014505 | 270 |
News Archive
Safety new medical providers can substantially increase their telemedicine services with modest investments in new staff and technology, a move that can help them expand patients' access to specialized medical care, according to a new RAND Corporation study.
In 2006, researchers published a widely reported study showing that for many patients who had suffered a heart attack more than 24 hours before and had a blocked coronary artery, certain heart procedures, such as balloon angioplasty and the insertion of stents, were no more effective than drugs alone. In 2007, the American Heart Association and the American College of Cardiology issued guidelines urging doctors to not use such treatments in those patients.
Major depressive disorder is a debilitating illness that affects more than 350 million people around the world.
SynAgile Corporation, a privately held pharmaceutical company that develops and commercializes drug delivery systems using its proprietary OraFuse intraoral technology platform, today announced positive results from a proof-of-concept, Phase 2a, open-label clinical trial of continuous intraoral administration of levodopa-carbidopa (LD/CD).
In a move that positions IP Advocate for its next chapter as a champion of research translation, founder Dr. Renee Kaswan today announced that she has settled her long-standing legal battle with the University of Georgia Research Foundation.
› Verified 9 days ago
Provider Name | Industrial Hand And Physical Therapy Inc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1124035258 PECOS PAC ID: 8325937907 Enrollment ID: O20040311001464 |
News Archive
Safety new medical providers can substantially increase their telemedicine services with modest investments in new staff and technology, a move that can help them expand patients' access to specialized medical care, according to a new RAND Corporation study.
In 2006, researchers published a widely reported study showing that for many patients who had suffered a heart attack more than 24 hours before and had a blocked coronary artery, certain heart procedures, such as balloon angioplasty and the insertion of stents, were no more effective than drugs alone. In 2007, the American Heart Association and the American College of Cardiology issued guidelines urging doctors to not use such treatments in those patients.
Major depressive disorder is a debilitating illness that affects more than 350 million people around the world.
SynAgile Corporation, a privately held pharmaceutical company that develops and commercializes drug delivery systems using its proprietary OraFuse intraoral technology platform, today announced positive results from a proof-of-concept, Phase 2a, open-label clinical trial of continuous intraoral administration of levodopa-carbidopa (LD/CD).
In a move that positions IP Advocate for its next chapter as a champion of research translation, founder Dr. Renee Kaswan today announced that she has settled her long-standing legal battle with the University of Georgia Research Foundation.
› Verified 9 days ago
Provider Name | Giardina Sports Medicine Consultants Inc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1013125483 PECOS PAC ID: 9931122942 Enrollment ID: O20060105000211 |
News Archive
Safety new medical providers can substantially increase their telemedicine services with modest investments in new staff and technology, a move that can help them expand patients' access to specialized medical care, according to a new RAND Corporation study.
In 2006, researchers published a widely reported study showing that for many patients who had suffered a heart attack more than 24 hours before and had a blocked coronary artery, certain heart procedures, such as balloon angioplasty and the insertion of stents, were no more effective than drugs alone. In 2007, the American Heart Association and the American College of Cardiology issued guidelines urging doctors to not use such treatments in those patients.
Major depressive disorder is a debilitating illness that affects more than 350 million people around the world.
SynAgile Corporation, a privately held pharmaceutical company that develops and commercializes drug delivery systems using its proprietary OraFuse intraoral technology platform, today announced positive results from a proof-of-concept, Phase 2a, open-label clinical trial of continuous intraoral administration of levodopa-carbidopa (LD/CD).
In a move that positions IP Advocate for its next chapter as a champion of research translation, founder Dr. Renee Kaswan today announced that she has settled her long-standing legal battle with the University of Georgia Research Foundation.
› Verified 9 days ago
Provider Name | Orthopedic Specialists Of North America Pllc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1770812828 PECOS PAC ID: 7719014505 Enrollment ID: O20100428000061 |
News Archive
Safety new medical providers can substantially increase their telemedicine services with modest investments in new staff and technology, a move that can help them expand patients' access to specialized medical care, according to a new RAND Corporation study.
In 2006, researchers published a widely reported study showing that for many patients who had suffered a heart attack more than 24 hours before and had a blocked coronary artery, certain heart procedures, such as balloon angioplasty and the insertion of stents, were no more effective than drugs alone. In 2007, the American Heart Association and the American College of Cardiology issued guidelines urging doctors to not use such treatments in those patients.
Major depressive disorder is a debilitating illness that affects more than 350 million people around the world.
SynAgile Corporation, a privately held pharmaceutical company that develops and commercializes drug delivery systems using its proprietary OraFuse intraoral technology platform, today announced positive results from a proof-of-concept, Phase 2a, open-label clinical trial of continuous intraoral administration of levodopa-carbidopa (LD/CD).
In a move that positions IP Advocate for its next chapter as a champion of research translation, founder Dr. Renee Kaswan today announced that she has settled her long-standing legal battle with the University of Georgia Research Foundation.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Douglas P Ostrander, MS, PT 18384 W Summerhaven Dr, Goodyear, AZ 85338-5369 Ph: () - | Douglas P Ostrander, MS, PT 10450 W Mcdowell Rd Ste 102, Avondale, AZ 85392-4901 Ph: (602) 648-5444 |
News Archive
Safety new medical providers can substantially increase their telemedicine services with modest investments in new staff and technology, a move that can help them expand patients' access to specialized medical care, according to a new RAND Corporation study.
In 2006, researchers published a widely reported study showing that for many patients who had suffered a heart attack more than 24 hours before and had a blocked coronary artery, certain heart procedures, such as balloon angioplasty and the insertion of stents, were no more effective than drugs alone. In 2007, the American Heart Association and the American College of Cardiology issued guidelines urging doctors to not use such treatments in those patients.
Major depressive disorder is a debilitating illness that affects more than 350 million people around the world.
SynAgile Corporation, a privately held pharmaceutical company that develops and commercializes drug delivery systems using its proprietary OraFuse intraoral technology platform, today announced positive results from a proof-of-concept, Phase 2a, open-label clinical trial of continuous intraoral administration of levodopa-carbidopa (LD/CD).
In a move that positions IP Advocate for its next chapter as a champion of research translation, founder Dr. Renee Kaswan today announced that she has settled her long-standing legal battle with the University of Georgia Research Foundation.
› Verified 9 days ago
Bradley Day, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 10721 W Indian School Rd, Avondale, AZ 85392 Phone: 623-772-7748 Fax: 480-860-0356 | |
Mr. Aaron Michael Spivey, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 13055 W Mcdowell Rd, Suite G-107, Avondale, AZ 85392 Phone: 623-547-4787 Fax: 623-547-4788 | |
Dr. Jennifer Nicole Martinez, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1665 N Avondale Blvd, Avondale, AZ 85392 Phone: 602-933-6084 | |
Julie Helfer, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 10721 W Indian School Rd, Avondale, AZ 85392 Phone: 623-772-7748 Fax: 623-772-7749 | |
Carlos Sifuentes, Physical Therapist Medicare: Medicare Enrolled Practice Location: 10750 W Mcdowell Rd., Ste. B-210, Avondale, AZ 85323 Phone: 623-907-0746 | |
Mr. Andy Martin Alanis Lafarga, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 10750 W Mcdowell Rd Ste B210, Avondale, AZ 85392 Phone: 623-907-0746 |